SCHEMBL10502481

SCHEMBL10502481

Cc1cccc(-n2[se]c3ccccc3c2=S)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 5/20 0.46
▸ MPI P34949 3/20 0.44
▸ PHOSPHO1 Q8TCT1 3/20 0.44
▸ PMM2 O15305 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ QSOX1 O00391 1/20 0.42
▸ RGS12 O14924 1/20 0.42
▸ PLIN1 O60240 1/20 0.42
▸ GMNN O75496 1/20 0.42
▸ BBOX1 O75936 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYBB P04839 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10502572 0.87 METAP2 (0.47) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501877 0.82 METAP2 (0.66) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501336 0.82 METAP2 (0.50) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501589 0.81 METAP2 (0.61) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501084 0.81 METAP2 (0.68) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501843 0.81 METAP2 (0.69) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501842 0.81 METAP2 (0.49) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501187 0.81 METAP2 (0.45) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501250 0.81 METAP2 (0.44) METAP2MPIPHOSPHO1PMM2ALDH1A1
SCHEMBL10501792 0.78 METAP2 (0.46) METAP2MPIPHOSPHO1PMM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback